Target intelligence / Profile preview

Regenerating family member 1 gamma, pseudogene (REG1CP)

Target
REG1CP
Molecular classification
Long non-coding RNA (lncRNA), Transcribed unprocessed pseudogene, Other
01

Overview

Regenerating family member 1 gamma, pseudogene (REG1CP) is a transcribed long non-coding RNA (lncRNA) located within the human REG gene cluster. Formerly considered a pseudogene, REG1CP is now recognized as having a functional regulatory role, particularly in the promotion of cancer cell proliferation and tumorigenesis. Mechanistically, REG1CP forms an RNA–DNA triplex with the promoter of the REG3A gene, recruiting FANCJ helicase to unwind DNA and facilitate glucocorticoid receptor α-mediated transcription of REG3A. This activity selectively increases REG3A expression, resulting in enhanced cell proliferation, and is implicated in poor prognosis in colorectal cancer. REG1CP is not a traditional therapeutic target (e.g., receptor, enzyme, transporter) but is a non-coding RNA regulator, and its categorization as a pseudogene has changed due to the discovery of its functional transcript[1][2][3][4][5][6].

Other names
REG1PREGLRS
02

Mechanism of action

Functions as a chromatin modulator by forming RNA–DNA triplexes to recruit FANCJ helicase and facilitate transcription of REG3A\nModulates histone modification states at target promoters

03

Biological functions

Regulation of gene transcription (notably REG3A)Chromatin modulation via RNA–DNA triplex formationCell proliferation (by upregulation of REG3A)Tumorigenesis (promotes cancer cell growth)Other
04

Disease associations

Cancer (colorectal and potentially other types)Other
05

Biomarkers

REG1CP expression (as a candidate biomarker for poor prognosis in colorectal cancer)

Beyond the preview

Go deeper on Regenerating family member 1 gamma, pseudogene (REG1CP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regenerating family member 1 gamma, pseudogene (REG1CP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call